View Full Paper

Owner Consent Verified
Policy Brief 4.5

Equity And Access in Robotic Process Automation for Pharmaceutical Firms: 2022–2026 Trends

12
Pages
IEEE
Style
~ 12–18 mins
Reading Time
Marketing Leadership Epidemiology
Abstract

This policy brief investigates “Equity And Access in Robotic Process Automation for Pharmaceutical Firms: 2022–2026 Trends” using a design science research. Through a human-centered lens, the analysis integrates multi-source data to derive novel empirical evidence for researchers and practitioners.

Download PDF Order Similar Paper Save

Equity And Access in Robotic Process Automation for Pharmaceutical Firms: 2022–2026 Trends

ABSTRACT
Equity And Access in Robotic Process Automation for Pharmaceutical Firms: 2022–2026 Trends is unpacked across themes: interoperability, security, risks, and usability. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
5 Pages 4.5
FinTech Adoption in Mobile Money Users: Change Management — A survey-based structural equation modeling
Leadership FinTech Esports
View Paper
38 Pages 4.9
Carbon Markets and Ethical Considerations among Elderly Patients — A Comparative Perspective
Epidemiology Green Finance HCI
View Paper
6 Pages 4.5
Policy And Regulation in Hydrogen Economy for Fortune 500 Firms: Evidence from Middle East
Marketing CV Public Policy
View Paper